Nanoparticle composition useful in cancer therapy comprises vesicle forming component, agent-entrapping component enclosed by vesicle-forming component; radionuclides entrapped on interior side of the composition.
Research output: Patent
Standard
Nanoparticle composition useful in cancer therapy comprises vesicle forming component, agent-entrapping component enclosed by vesicle-forming component; radionuclides entrapped on interior side of the composition. / Kjær, Andreas (Inventor).
Patent No.: WO2011006510-A1.Research output: Patent
Harvard
Kjær, A, Nanoparticle composition useful in cancer therapy comprises vesicle forming component, agent-entrapping component enclosed by vesicle-forming component; radionuclides entrapped on interior side of the composition., Patent No. WO2011006510-A1.
APA
Kjær, A. (2011). Nanoparticle composition useful in cancer therapy comprises vesicle forming component, agent-entrapping component enclosed by vesicle-forming component; radionuclides entrapped on interior side of the composition. (Patent No. WO2011006510-A1).
Vancouver
Kjær A, inventor. Nanoparticle composition useful in cancer therapy comprises vesicle forming component, agent-entrapping component enclosed by vesicle-forming component; radionuclides entrapped on interior side of the composition. WO2011006510-A1. 2011.
Author
Bibtex
@misc{71c140573c354f27bb147764be15626c,
title = "Nanoparticle composition useful in cancer therapy comprises vesicle forming component, agent-entrapping component enclosed by vesicle-forming component; radionuclides entrapped on interior side of the composition.",
author = "Andreas Kj{\ae}r",
year = "2011",
language = "English",
type = "Patent",
note = "WO2011006510-A1",
}
RIS
TY - PAT
T1 - Nanoparticle composition useful in cancer therapy comprises vesicle forming component, agent-entrapping component enclosed by vesicle-forming component; radionuclides entrapped on interior side of the composition.
AU - Kjær, Andreas
PY - 2011
Y1 - 2011
M3 - Patent
M1 - WO2011006510-A1
ER -
ID: 40215512